Insider Transactions in Q2 2024 at Harvard Bioscience Inc (HBIO)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
            Jun 13                          
            2024                          
           | James W Green Director | 
              BUY
             
                Open market or private purchase
             | Direct | 
              10,000
              +0.32%
           | 
              $20,000              
              $2.91 P/Share              
           | 
| 
            Jun 06                          
            2024                          
           | James W Green Director | 
              BUY
             
                Open market or private purchase
             | Direct | 
              20,000
              +0.64%
           | 
              $60,000              
              $3.07 P/Share              
           | 
| 
            May 21                          
            2024                          
           | Thomas W Loewald Director | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              45,872
              +13.45%
           | 
              -                 
           | 
| 
            May 21                          
            2024                          
           | Bertrand Loy Director | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              56,575
              +50.0%
           | 
              -                 
           | 
| 
            May 21                          
            2024                          
           | Alan I Edrick Director | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              45,872
              +14.34%
           | 
              -                 
           | 
| 
            May 21                          
            2024                          
           | Katherine A. Eade Director | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              45,872
              +12.85%
           | 
              -                 
           |